Home News Point72

Point72
Alto Neuroscience Secures $45M in Game-Changing Series C Round for Mental Health Breakthroughs
– New investors include InVivium Capital, Franklin Templeton, Point72, Eli Lilly and Company, and Alexandria Venture Investments –– Funds will be used to support ongoing and planned late-stage clinical development of CNS product candidates with four Phase 2 readouts expected across the nex
Nov 21, 2023
Follow us: